News & Views

Clinical practice

The Case of the Explicit Exposure

Mr. Larsen presents to the clinic for his first dose of R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone) for a diagnosis of diffuse large B-cell lymphoma. Elizabeth, his oncology nurse, just started the cyclophosphamide when she is paged to the desk for a call from Mr. Larsen’s oncologist. She quickly removes her face shield and gloves as she hurriedly leaves the room to take the call. After completing the call, she returns to Mr. Larsen’s room to remove her gown.

Trending Topics

View All Topics

Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment?

Clinical practice

Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment?

How to Prepare for a Career in Oncology Nursing

How to Prepare for a Career in Oncology Nursing

Magnet Status Benefits Physicians, Too

Magnet Status Benefits Physicians, Too

Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Because of the Potential for Glass Particulate

U.S. Food and Drug Administration (FDA)

Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Because of the Potential for Glass Particulate

Telehealth Programs Improve Symptom Management at Home

Clinical practice

Telehealth Programs Improve Symptom Management at Home

Collaboration Is Key to CAR T-Cell Therapy Management Across Settings

Collaboration Is Key to CAR T-Cell Therapy Management Across Settings

The Work We Do Now Affects Healthcare’s Future

Nurse empowerment

The Work We Do Now Affects Health Care’s Future

Here’s How You Can Confront Workplace Violence in a Healthcare Setting

Here’s How You Can Confront Workplace Violence in a Healthcare Setting

FDA Grants Accelerated Approval to Selinexor for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Selinexor for Multiple Myeloma

Test Predicts Which Women Will Benefit From Chemo for Breast Cancer

Test Predicts Which Women Will Benefit From Chemo for Breast Cancer

Support and Empower At-Home Caregivers of Patients With Cancer

Caregiver support

Support and Empower At-Home Caregivers of Patients With Cancer

No Place Like It: Home Care for Patients With Cancer

Clinical practice

No Place Like It: Home Care for Patients With Cancer

FDA Approves Daratumumab for Multiple Myeloma Ineligible for Autologous Stem Cell Transplant

U.S. Food and Drug Administration (FDA)

FDA Approves Daratumumab for Multiple Myeloma Ineligible for Autologous Stem Cell Transplant

American Academy of Nursing Inducts Six ONS Members as 2019 Fellows

Beta Data Browser Puts Precision Medicine Cohort at Researchers’ Fingertips

Oncology nurse scientist

Beta Data Browser Puts Precision Medicine Cohort at Researchers’ Fingertips

New CAR T-Cell Targets Show Safe Results in Early Clinical Trials

New CAR T-Cell Targets Show Safe Results in Early Clinical Trials

FDA’s Latest Approved Drugs and Indications Include Two Oral Agents

U.S. Food and Drug Administration (FDA)

FDA’s Latest Approved Drugs and Indications Include Two Oral Agents

Early Studies Show Cancer Vaccines Are Promising for Lynch Syndrome, Cervical Lesions

Early Studies Show Cancer Vaccines Are Promising for Lynch Syndrome, Cervical Lesions

Combination Trastuzumab and Hyaluronidase-Oysk

Oncology Drug Reference Sheet: Combination Trastuzumab and Hyaluronidase-Oysk

FDA Approves Pembrolizumab for Metastatic Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for Metastatic Small Cell Lung Cancer

Innovative Technology Improves Provider Education on Distress Management for Cancer Survivors

Cancer prevention

Innovative Technology Improves Provider Education on Distress Management for Cancer Survivors

6 or 9? Why Persuasive Public Speaking Is Essential

6 or 9? Why Persuasive Public Speaking Is Essential

FDA Links Breast Implants to Increased ALCL Risk

U.S. Food and Drug Administration (FDA)

FDA Links Breast Implants to Increased ALCL Risk

FDA Approves Pembrolizumab for First-Line Treatment of HNSCC

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for First-Line Treatment of HNSCC

How Music Can Soothe Your Savage Beast—Stress

Nurse self-care

How Music Can Soothe Your Savage Beast—Stress

Survivorship Considerations After CAR T-Cell Therapy

Survivorship Considerations After CAR T-Cell Therapy

FDA Approves Polatuzumab Vedotin-piiq for Diffuse Large B-Cell Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Polatuzumab Vedotin-piiq for Diffuse Large B-Cell Lymphoma

Manage Immunotherapy-Related Diarrhea and Colitis

Advanced practice nursing (APN)

Manage Immunotherapy-Related Diarrhea and Colitis

Less Toxic CAR T-Cell Therapy May Be on the Horizon

Less Toxic CAR T-Cell Therapy May Be on the Horizon

Nurses Are Crucial to Developing Tools, Best Practices for Novel Therapies

Oncology nurse researcher

Nurses Are Crucial to Developing Tools, Best Practices for Novel Therapies

Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care

Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care

Think Tank Will Explore Nurse Leadership Development Initiatives

Think Tank Will Explore Nurse Leadership Development Initiatives

FDA Updates REMS and Black Box Warnings for Blinatumomab

U.S. Food and Drug Administration (FDA)

FDA Updates REMS and Black Box Warnings for Blinatumomab

FDA Approves Lenalidomide for Follicular and Marginal Zone Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Lenalidomide for Follicular and Marginal Zone Lymphoma

How ONS Is Supporting ONNs’ Professional Development

Nurse navigator

How ONS Is Supporting ONNs’ Professional Development

FDA Approves Alpelisib for Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Alpelisib for Metastatic Breast Cancer

Practice These Five Self-Care Strategies in Less Than Five Minutes

Nurse self-care

Practice These Five Self-Care Strategies in Less Than Five Minutes

FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease

U.S. Food and Drug Administration (FDA)

FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease

FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries

U.S. Food and Drug Administration (FDA)

FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries

Oncology Drug Reference Sheet: Talazoparib (Talzenna®)

Oncology Drug Reference Sheet: Talazoparib

Commission on Cancer to Revise Standards for Cancer Program Accreditation

Commission on Cancer to Revise Standards for Cancer Program Accreditation

Commit to Protect and Care for Yourself During Oncology Nursing Month

Commit to Protect and Care for Yourself During Oncology Nursing Month

FDA Approves Venetoclax for CLL and SLL

U.S. Food and Drug Administration (FDA)

FDA Approves Venetoclax for CLL and SLL

Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy

Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy

FDA Approves Avelumab Plus Axitinib for Renal Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Avelumab Plus Axitinib for Renal Cell Carcinoma

Acupuncture for Cancer-Related Fatigue

Complementary therapy

Acupuncture for Cancer-Related Fatigue

The Case of the Terrible Toxicities

The Case of the Terrible Toxicities

Everyone Means Me, Everyone Includes You: Improving the Practice of Cancer Screening

Cancer prevention

Everyone Means Me, Everyone Includes You: Improving the Practice of Cancer Screening

Liquid Biopsy Equivalent to Tissue for NSCLC

Liquid Biopsy Equivalent to Tissue for NSCLC

Back to Top ▲